OncoImmunology
Volume 6, 2017 - Issue 10
Open access
1,658
Views
9
CrossRef citations to date
0
Altmetric
Review
No patient left behind: The promise of immune priming with epigenetic agents
Corey A. CarterWalter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, MD, USACorrespondence[email protected]
, Bryan T. OronskyEpicentRx, Inc., San Diego, CA, USA
, Joseph RoswarskiWalter Reed National Military Medical Center, Murtha Cancer Center, Bethesda, MD, USA
, Arnold L. OronskyInterWest Partners, Menlo Park, CA, USA
, Neil OronskyCFLS Data, San Jose, CA, USA
, Jan ScicinskiEpicentRx, Inc., San Diego, CA, USA
, Harry LybeckUniversity of Helsinki, Department of Physiology, Helsinki, Finland
, Michelle M. KimUniversity of Michigan, Department of Radiation Oncology, Ann Arbor, MI, USA
, Michelle LybeckEpicentRx, Inc., San Diego, CA, USA
& Tony R. ReidUniversity of California San Diego, Moores Cancer Center, La Jolla, CA, USA
show all
Article: e1315486
|
Received 11 Jul 2016, Accepted 30 Mar 2017, Published online: 15 Sep 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.